Amarantus Bioscience Holdings, Inc. 2H-2014: Milestones Ahead to Position Amarantus for the Up-list - Siouxland News - KMEG 14 and FOX 44

Amarantus Bioscience Holdings, Inc. 2H-2014: Milestones Ahead to Position Amarantus for the Up-list

Posted: Updated:

New York, NY / June 18, 2014 / Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS) today published a new blog post on The Chairman’s Blog, written by the Company’s CEO, Mr. Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his new blog, President and CEO Gerald Commissiong discusses the significant transformation and progress he believes the Company has made throughout the first half of 2014 and what strategic events are planned for the next six months. He writes, “We have a clear plan and strategy, and are working to establish appropriate channels for scientific, development and financial partnerships that will provide near and long-term value creation possibilities across multiple fronts.” Read the full blog post from Mr. Gerald Commissiong on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/).

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine (“Eltoprazine”), a phase 2b ready indication for Parkinson’s Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test(r)”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”) and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson’s disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

 

SOURCE: TheChairmansBlog.com

ReleaseID: 416980

  • Local News | <a href="http://www.siouxlandnews.com//category/108597/local-news">More >></a><!-- JS-KIT codeword=woct -->Local NewsMore>>

  • Immigration Debate Has Impact on Siouxland

    Immigration Debate Has Impact on Siouxland

    (SIOUX CITY, IA) The immigration debate is having an impact locally, with one local group lobbying to bring 1,000 of the undocumented children to Iowa.More >>
    (SIOUX CITY, IA) The immigration debate is having an impact locally, with one local group lobbying to bring 1,000 of the undocumented children to Iowa.
    More >>
  • Early Morning Attic Fire Caused by Electrical Malfunction

    Early Morning Attic Fire Caused by Electrical Malfunction

    (SIOUX CITY, IA) Sioux City fire marshals have determined the cause of an early morning house fire that caused heavy damage to the roof and water damage to the rest of the home.More >>
    (SIOUX CITY, IA) Sioux City fire marshals have determined the cause of an early morning house fire that caused heavy damage to the roof and water damage to the rest of the home.
    More >>
  • Jay Leno to Host Girls Inc. 10th Anniversary Benefit

    Jay Leno to Host Girls Inc. 10th Anniversary Benefit

    (SIOUX CITY, IA) At a press conference on Tuesday, Girls Inc. announced former Tonight Show host Jay Leno will be coming to the Orpheum Theatre for their 10th anniversary Benefit.More >>
    (SIOUX CITY, IA) At a press conference on Tuesday, Girls Inc. announced former Tonight Show host Jay Leno will be coming to the Orpheum Theatre for their 10th anniversary Benefit.
    More >>
Powered by WorldNow

Siouxland News
100 Gold Circle
Dakota Dunes, SD 57049

Main Phone: 712-277-3554
Main Fax: 712-255-5250
Email: webmaster@siouxlandnews.com

Powered by WorldNow
All content © Copyright 2000 - 2009 WorldNow and Sinclair Communications, LLC. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.